So, if weve got a population thats already at high risk for a lot of these things and then theyre getting slammed on too high doses of this peptide, we have a problem
It may also be used according to your healthcare providers recommendations
Semaglutide and clinical atherosclerotic cardiovascular event data Regulatory authorities recognized that GLP-1 analogues reduce the incidence of MACEs in T2DM patients, but this is only the case for GLP-1R agonists with a molecular structure based on endogenous GLP-1 (semaglutide, liraglutide, albiglutide, and dulaglutide), as they are able to reduce the relative risk of MACEs by up to 10% [43]
doi:10.3390/applmicrobiol1030040
The certificate of analysis should include the HPLC chromatogram, a mass spectrometry identity trace matching 5135.9 Da, and an endotoxin measurement below 5 EU per mg